3 tracked superinvestors hold BRISTOL-MYERS SQUIBB CO (BMY), worth $1.4B combined, led by PRIMECAP team. Smart money is trimming BMY as of the latest 13F filings.
Current price
$66.82
+50.0%
1Y
Bristol-Myers Squibb Company operates as a global biopharmaceutical entity, actively involved in the research, development, licensing, production, and worldwide commercialization of its medicinal portfolio. The company's therapeutic areas span hematology, oncology, cardiovascular health, immunology, fibrotic conditions, neuroscience, and infectious diseases like COVID-19. Its significant…
Market cap
$118.9B
P/E
16.31
Div yield
3.8%
Revenue YoY
-0.2%
Analyst target
$69
Snapshot for context. For deep analysis use a stock screener — this page is about who owns it.
Superinvestors holding
3
tracked 13F / N-PORT funds
Combined value
$1.4B
disclosed long exposure
Tier-1 conviction
1
concentrated holders
Net this quarter
-1
0 buying · 1 selling
Smart money is net reducing BMY: 1 funds trimmed versus 0 adding.
BRISTOL-MYERS SQUIBB CO (BMY) is held by 3 tracked funds worth $1.4B combined, 1 of them concentrated Tier-1 managers whose positions carry real conviction.
The largest position belongs to PRIMECAP team at 0.9% of their book — no single tracked manager treats it as an outsized, top-weighted bet.
No tracked fund opened a new position this quarter; 0 added and 1 trimmed, a net reduction.
| Investor | Move | % of their portfolio | Position value |
|---|---|---|---|
| Held | 0.9% | $824M | |
| Trimmed | 0.4% | $582M | |
| Held | 1% | $4M |
Tier badge = signal quality: 1 concentrated conviction · 2 quant/multi (context) · 3 retail & diversified. Only Tier 1 holdings feed the consensus signal.
Which superinvestors own BMY?
3 tracked funds hold BRISTOL-MYERS SQUIBB CO (BMY), the largest being PRIMECAP team (Vanguard PRIMECAP) at 0.9% of its 13F portfolio. 1 of them are concentrated Tier-1 conviction managers.
Is smart money buying or selling BMY?
In the most recent 13F quarter, 0 tracked funds added or opened BMY and 1 trimmed it.
How much BMY do tracked funds hold?
Combined disclosed long exposure to BMY across tracked superinvestors is $1.4B as of the Jun 2026 filings.
One email when a tracked manager opens, adds to or files to sell a position — from Form 4, 13D and Form 144, not the 45-day-old 13F.
Holdings aggregated from the latest SEC 13F & N-PORT filings via FMP · Jun 2026 quarter. Long equity positions only, reported with up to a 45-day delay — for activity between filings see real-time moves. Not financial advice.